EndeavorRx is FDA-approved, evaluated in over 600 children with ADHD across 5 clinical studies.

In our randomized, controlled clinical study¹, EndeavorRx improved objective attention in children with ADHD ages 8-12.

Patients played for ~25 minutes per day, 5 days per week, for 4 weeks – and a more recent trial demonstrated that a second month of treatment can lead to increased benefits.

¹STARS-ADHD Pivotal Study: Kollins et al, Lancet Digital Health, 2020.

By The Numbers

68% of parents reported improvements in ADHD-related impairments after two months of treatment.²

73% of children reported an improvement in their attention.³

0% There were no serious adverse events seen in any clinical trials of EndeavorRx.²,³

Want to see the full summary?

If you’re interested in a more detailed summary of our clinical studies, you can download it here

² STARS-ADHD-Adjunctive: Kollins et al, npj digital medicine, 2021.
³ STARS-ADHD Pivotal Study: Kollins et al, Lancet Digital Health, 2020. Data from a “Yes-No” Exit Survey.

Start a virtual appointment

Want a prescription now? You can talk anytime to a healthcare professional via our telemedicine partner.

Talk to a healthcare professional

Want us to send your doctor info on EndeavorRx?

Provide us with their contact information and we’ll reach out directly, so your child’s doctor has all the resources you both need to get started.

Need help talking to your doctor about EndeavorRx?

Use this simple guide to start a conversation with your child’s healthcare professional.

Have more questions?

Check our FAQ page or use the Contact Us page to reach us directly.

Stay up to date with EndeavorRx

Curious about EndeavorRx and wondering if it’s right for your child? Just complete this form to get more information & receive our latest updates.

By submitting this form, you consent to Akili processing your data or personal information in accordance with our Privacy Notice and agree to the Terms of Use of our sites.

EndeavorRx:

Indications, Safety and Cautions

Indications:
EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of Variables of Attention (TOVA®), of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.

Safety:
Of 538 participants using EndeavorRx, 50 participants (9.3%) experienced treatment-related adverse events (probable, likely), and three participants experienced treatment-related adverse events with the digital control, in studies where a control was used. EndeavorRx associated adverse events included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). There were no serious adverse events. All adverse events were generally transient. Only 3 events led to device discontinuation, and no subject reported lasting or irreversible effects after discontinuation.

Cautions:
Rx only: Federal law restricts this device to sale by or on the order of a physician. EndeavorRx should only be used by the patient for whom the prescription was written. For medical questions, please contact your child’s healthcare provider. If you are experiencing a medical emergency, please dial 911. EndeavorRx is not intended to be used as a stand-alone therapeutic and is not a substitution for your child’s medication.

If your child experiences frustration, emotional reaction, dizziness, nausea, headache, eye-strain, or joint pain while playing EndeavorRx pause the treatment. If the problem persists contact your child’s healthcare provider. If your child experiences a seizure stop the treatment and contact your child’s healthcare provider.

EndeavorRx may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device; parents should consult with their child’s healthcare provider.

Please follow all of your mobile device manufacturer’s instructions for the safe operation of your mobile device. For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device.